AFTER: Altering Fat Through Estrogen and Raloxifene

NCT00149604 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

108

Enrollment

NIH

Sponsor class

Conditions

Postmenopause

Interventions

DRUG: conjugated estrogens
DRUG: Raloxifene
BEHAVIORAL: exercise plus mild caloric restriction for weight loss

Sponsor

National Institute on Aging (NIA)